Hutchmed (China)
HCM
Ermenegildo Zegna NV
ZGN
New Fortress Energy
NFE
Enerpac Tool
EPAC
eBay
EBAY
US Stock MarketDetailed Quotes
AKBA Akebia Therapeutics
- 2.0700
- +0.1400+7.25%
Close Jan 17 16:00 ET
- 2.0800
- +0.0100+0.48%
Post 19:58 ET
451.64MMarket Cap-9.41P/E (TTM)
2.0900High1.9200Low6.52MVolume1.9500Open1.9300Pre Close12.95MTurnover3.29%Turnover RatioLossP/E (Static)218.18MShares2.480052wk High-8.96P/B410.43MFloat Cap0.800052wk Low--Dividend TTM198.27MShs Float31.0000Historical High--Div YieldTTM8.81%Amplitude0.2410Historical Low1.9850Avg Price1Lot Size
About Akebia Therapeutics Company
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
Company Profile
SymbolAKBA
Company NameAkebia Therapeutics
Listing DateMar 20, 2014
Issue Price17.00
Founded2007
CEOMr. John P. Butler
MarketNASDAQ
Employees167
Fiscal Year Ends12-31
Address245 First Street,Suite 1400
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-871-2098
Websitehttp://www.akebia.com
Company Executives
- Name
- Position
- Salary
- John P. Butler
- Director, President and Chief Executive Officer
- 2.78M
- Richard C. Malabre
- Chief Accounting Officer
- --
- Erik John Ostrowski
- Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer
- --
- Dr. Steven Keith Burke, M.D.
- Senior Vice President, Research and Development and Chief Medical Officer
- 1.21M
- Nicholas Grund
- Senior Vice President and Chief Commercial Officer
- --
- Adrian Adams
- Chairman of the Board
- 171.63K
- Cynthia Smith
- Independent Director
- 151.50K
- Dr. Myles Wolf, M.D.
- Independent Director
- 144.43K
- Ronald E. Frieson
- Independent Director
- 147.97K
- LeAnne M. Zumwalt
- Independent Director
- 143.31K
- Michael W. Rogers
- Independent Director
- 145.79K
- Dr. Steven C. Gilman, PhD
- Independent Director
- 139.87K